Transdermal Buprenorphine Dosing Interval Optimization from 7 Days to 5 Days: A Case Series.
Saved in:
| Title: | Transdermal Buprenorphine Dosing Interval Optimization from 7 Days to 5 Days: A Case Series. |
|---|---|
| Authors: | Curtis H; Boise VA Medical Center, Boise, Idaho, USA., Bailey N; Boise VA Medical Center, Boise, Idaho, USA., Dickey K; Boise VA Medical Center, Boise, Idaho, USA., Ineck J; Boise VA Medical Center, Boise, Idaho, USA. |
| Source: | Journal of pain & palliative care pharmacotherapy [J Pain Palliat Care Pharmacother] 2026 Jun; Vol. 40 (2), pp. 369-374. Date of Electronic Publication: 2026 Apr 04. |
| Publication Type: | Journal Article; Case Reports |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 101125608 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-0539 (Electronic) Linking ISSN: 15360288 NLM ISO Abbreviation: J Pain Palliat Care Pharmacother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1536-0539 |
|---|---|
| DOI: | 10.1080/15360288.2026.2653549 |
